Zero Fluoroscopy Transcatheter Device Closure in Subaortic Ventricular Septal Defect

Authors

  • Marco Wirawan Hadi Cardiovascular Department, Faculty of Medicine, Diponegoro University/ Kariadi Hospital, Semarang, Indonesia https://orcid.org/0000-0002-7373-1379
  • Tahari Bargas Prakoso Cardiovascular Department, Faculty of Medicine, Diponegoro University/ Kariadi Hospital, Semarang, Indonesia
  • Rille Puspitoadhi Harjoko Cardiovascular Department, Faculty of Medicine, Diponegoro University/ Kariadi Hospital, Semarang, Indonesia https://orcid.org/0000-0003-4017-1747
  • Sefri Noventi Sofia Cardiovascular Department, Faculty of Medicine, Diponegoro University/ Kariadi Hospital, Semarang, Indonesia https://orcid.org/0000-0003-1126-0396

DOI:

https://doi.org/10.36408/mhjcm.v12i2.1289

Keywords:

ventricular septal defect closure, zero fluoroscopy, echocardiography-guided

Abstract

Background: For the last decade, transcatheter closure of ventricular septal defect (VSD) has been the treatment of choice, using fluoroscopy as a guide. However, the risk of radiation and/or contrast agent exposure has been an issue, especially in young patients. We would like to highlight the first case of zero fluoroscopy transcatheter VSD closure in Central Java.

Case Illustration: A 27-year-old female was referred to outpatient department due to worsening shortness of breath in the last 3 months before admission. She had a history of recurrent respiratory tract infections, feeding difficulty, and failure to thrive. Her vital signs were stable, 99% oxygen saturation, and grade 3/6  pansystolic murmur in the lower left sternal border. Transoesophageal echocardiography showed 3 mm subaortic VSD, left to right shunt. Transcatheter VSD closure was successfully done using Konar-MF™ VSD Occluder No. 8/6 mm retrograde approach without fluoroscopy.

Conclusion: The first zero fluoroscopy transcatheter device closure in Central Java has been successfully done in a 27-year-old female with subaortic VSD. Zero fluoroscopy transcatheter VSD closure is a feasible, safe, and effective procedure.

Downloads

Download data is not yet available.

References

1.     Minette MS, Sahn DJ. Ventricular septal defects. Circulation 2006; 114: 2190–2197.
2.     Prakoso R, Ariani R, Lilyasari O, Kurniawati Y, Siagian SN, Sakidjan I, et al. Percutaneous atrial septal defect closure using transesophageal echocardiography without fluoroscopy in a pregnant woman: A case report. Med J Indones 2020; 29: 228–232.
3.     Siagian SN, Prakoso R, Mendel B, Hazami Z, Putri VYS, Zulfahmi, et al. Transesophageal echocardiography-guided percutaneous closure of multiple muscular ventricular septal defects with pulmonary hypertension using single device: A case report. Front Cardiovasc Med 2023; 10: 1–5.
4.     Hill NE, Giampetro DM. Fluoroscopy Contrast Materials, http://www.ncbi.nlm.nih.gov/pubmed/33240462 (2024).
5.     Andreucci M, Solomon R, Tasanarong A. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. Biomed Res Int 2014; 2014: 741018.
6.     Baumgartner H, de Backer J, Babu-Narayan S V., Budts W, Chessa M, Diller GP, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 2021; 42: 563–645.
7.     Kanaan M, Ewert P, Berger F, Assa S, Schubert S. Follow-up of patients with interventional closure of ventricular septal defects with Amplatzer Duct Occluder II. Pediatr Cardiol 2015; 36: 379–85.
8.     Singab H, Elshahat MK, Taha AS, Ali YA, El-Emam AM, Gamal MA. Transcatheter versus surgical closure of ventricular septal defect: a comparative study. Cardiothorac Surg 2023; 31: 8.
9.     Chen GL, Li HT, Li HR, Zhang ZW. Transcatheter closure of ventricular septal defect in patients with aortic valve prolapse and mild aortic regurgitation: Feasibility and preliminary outcome. Asian Pac J Trop Med 2015; 8: 315–318.
10.     Zhang W, Wang C, Liu S, Zhou L, Li J, Shi J, et al. Safety and Efficacy of Transcatheter Occlusion of Perimembranous Ventricular Septal Defect with Aortic Valve Prolapse: A Six-Year Follow-Up Study. J Interv Cardiol 2021; 2021: 6634667.
11.     Tim Penyusun PPK. Penutupan defek septum ventrikel dengan device tanpa fluoroskopi. In: Panduan Praktik Klinis PJN Harapan Kita. Jakarta: Lembaga PJN Harapan Kita, 2023, pp. 541–5.
12.     PERKI. Panduan Tatalaksana Penyakit Jantung Bawaan pada Pediatrik. 2nd ed. Jakarta, https://inaheart.org/wp-content/uploads/2021/07/Pedoman_Tatalaksana_Gagal_Jantung_2020.pdf (2024).
13.     Thakkar B, Patel N, Bohora S, Bhalodiya D, Singh T, Madan T, et al. Transcatheter device closure of perimembranous ventricular septal defect in children treated with prophylactic oral steroids: acute and mid-term results of a single-centre, prospective, observational study. Cardiol Young 2016; 26: 669–76.
14.     Carminati M, Butera G, Chessa M, De Giovanni J, Fisher G, Gewillig M, et al. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J 2007; 28: 2361–8.
15.     Holzer R, de Giovanni J, Walsh KP, Tometzki A, Goh T, Hakim F, et al. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry. Catheter Cardiovasc Interv 2006; 68: 620–8.
16.     Predescu D, Chaturvedi RR, Friedberg MK, Benson LN, Ozawa A, Lee K-J. Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg 2008; 136: 1223–8.

Additional Files

Published

2025-07-31

How to Cite

1.
Hadi MW, Prakoso TB, Harjoko RP, Sofia SN. Zero Fluoroscopy Transcatheter Device Closure in Subaortic Ventricular Septal Defect. Medica Hospitalia J. Clin. Med. [Internet]. 2025 Jul. 31 [cited 2025 Aug. 2];12(2):216-20. Available from: https://medicahospitalia.rskariadi.co.id/index.php/mh/article/view/1289

Citation Check

Most read articles by the same author(s)